allegro industries

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

– Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A.

The new contract with Pall will establish a suspension-based manufacturing platform of up to 2000L, using a range of technologies including Allegro STR single-use bioreactors. The new installation allows for the production of a variety of viral vectors for gene therapies and viral vector-based vaccines.

Exothera recently announced a significant expansion of its manufacturing capabilities, with two new state-of-the-art Good Manufacturing Practice (GMP) facilities built at the company’s Jumet site near Brussels, Belgium . The new facilities, which are roughly 92,000 square feet and include a variety of functions from research and development to commercial production, will begin GMP production this summer.

Clive Glover , General Manager, Gene Therapy at Pall Corporation, said: “There is a strong pipeline of viral vector-based gene therapies and vaccines and the importance of rapidly realizing industrial-scale production for these vaccines and therapies has been brought into sharp focus by COVID-19. Pall has considerable process development expertise from working with many of the industry leaders to develop scalable upstream and downstream processes. We’re thrilled to bring this experience to support Exothera as they expand their manufacturing capabilities.”

The gene therapy and vaccine industries are facing complex challenges when scaling up vector-based processes. According to Vasily Medvedev , head of development at Exothera, the company selected the Pall end-to-end solution based on its flexibility and its capability to scale up processes quickly and efficiently.

“We selected Pall for their technological excellence and strong track record in the gene therapy and vaccines industries, as well as the level of support the team provides,” explained Medvedev. “They offer a robust and cost-effective single-use solution.”

Christian Borgniet, Chief Operating Officer of Exothera, added: “Compared to other suspension solutions, Pall’s STR bioreactors are well-suited and could be adapted, if needed, to the perfusion mode, allowing higher growth and density of cells. We are pleased to establish this partnership with a very supportive company that is willing to transfer its expertise.”

About Pall Corporation
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit https://www.pall.com .

Or follow us on social media:

LinkedIn Twitter Facebook

Corporate Media Contact:
Pall Corporation
Amanda Comeau
Director, Corporate Communications
(508) 330-0811

About Exothera SA
Exothera is a viral vector CDMO (contract manufacturing and development organization) leveraging standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

LinkedIn : https://www.linkedin.com/company/exothera / Website : www.exothera.world

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/pall-corporation-secures-multi-million-dollar-contract-with-exothera-301323764.html

SOURCE Pall Corporation

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Livium Ltd

Livium Signs Binding Term Sheet with Iondrive related to DES Technology for Clean Energy Waste Recycling

Livium Ltd (ASX: LIT) ("Livium" or the "Company") is pleased to announce it has signed a binding term sheet (“Term Sheet”) with Iondrive Limited (ASX: ION) (“Iondrive”), an Australian company developing an innovative metal extraction process using Deep Eutectic Solvent technology (DES), via their subsidiary Iondrive AU Pty Ltd.

Keep reading...Show less
Glowing digital battery icon with particle connections on dark background.

CATL Mine Restart Pressures Australian Lithium Market

Australia’s lithium sector is facing pressure on the back of news that Chinese battery giant Contemporary Amperex Technology (CATL) (SZSE:300750,HKEX:3750) is expected to resume production at its Jianxiawo mine.

Operations were halted in August when the mine’s licence expired, with the suspension expected to last three months.

Located in Yichun, Jiangxi province, Jianxiawo produces about 65,000 tonnes of lithium carbonate equivalent annually, roughly 6 to 8 percent of global supply. It is the largest mine in Yichun, often referred to as China’s “lithium capital.”

Keep reading...Show less
International Lithium (TSXV:ILC)

International Lithium Corp.


Keep reading...Show less
Blue lithium-ion battery over shiny surface.

How to Invest in Lithium Stocks and the Lithium Market

Despite the current low price environment, the long-term demand for battery metals is robust and offers opportunity for those interested in lithium stocks.

Seasoned metals investors who want to look beyond gold and silver are getting involved, while new investors are being drawn in by expanding battery market and lithium supply deals between automakers and lithium producers.

Whatever the reason, it’s important to get familiar with the lithium market before investing in lithium stocks. Here's a brief overview of some of the basics, including supply and demand, prices and companies.

Keep reading...Show less

Latest Press Releases

Related News